Skip to main content
. 2016 Feb 16;13(2):e1001958. doi: 10.1371/journal.pmed.1001958

Table 2. Cross-protection parameter estimates by province.

Province k^(95%CI) δ^(95%CI) k^δ^(95%CI)
Beijing 21 (9, 25) 1.00 (0.65, 1.00) 21.00 (8.25, 25.00)
Tianjin 22 (2, 31) 1.00 (0.40, 1.00) 22.00 (1.80, 31.00)
Hebei 4 (3, 4) 1.00 (0.80, 1.00) 4.00 (2.85, 3.80)
Shanxi 0 (0, 52) 0.05 (0.00, 1.00) 0.00 (0.00, 5.20)
Inner Mongolia 2 (0, 52) 0.05 (0.00, 1.00) 0.10 (0.00, 33.80)
Liaoning 4 (3, 8) 1.00 (0.70, 1.00) 4.00 (3.00, 8.00)
Jilin 2 (0, 52) 0.95 (0.00, 1.00) 1.90 (0.00, 3.20)
Heilongjiang 52 (0, 52) 0.10 (0.00, 1.00) 5.20 (0.00, 13.00)
Shanghai 9 (6, 18) 1.00 (0.60, 1.00) 9.00 (5.20, 18.00)
Jiangsu 8 (1, 14) 0.40 (0.10, 1.00) 3.20 (0.55, 7.65)
Zhejiang 8 (3, 9) 0.65 (0.40, 1.00) 5.20 (2.55, 8.00)
Anhui 9 (1, 16) 0.30 (0.05, 1.00) 2.70 (0.05, 7.65)
Fujian 6 (3, 8) 1.00 (0.80, 1.00) 6.00 (3.00, 8.00)
Jiangxi 0 (0, 52) 0.05 (0.00, 1.00) 0.00 (0.00, 4.50)
Shandong 4 (3, 7) 1.00 (0.65, 1.00) 4.00 (2.25, 7.00)
Henan 6 (4, 6) 1.00 (0.60, 1.00) 6.00 (3.00, 5.70)
Hubei 2 (0, 52) 1.00 (0.00, 1.00) 2.00 (0.00, 9.00)
Hunan 6 (5, 8) 0.35 (0.15, 0.55) 2.10 (0.90, 3.30)
Guangdong 11 (11, 12) 1.00 (1.00, 1.00) 11.00 (11.00, 12.00)
Guangxi 9 (8, 14) 1.00 (0.95, 1.00) 9.00 (8.00, 14.00)
Hainan 0 (0, 52) 0.05 (0.00, 1.00) 0.00 (0.00, 3.25)
Chongqing 3 (2, 52) 1.00 (0.05, 1.00) 3.00 (1.20, 6.90)
Sichuan 6 (5, 8) 1.00 (0.30, 1.00) 6.00 (1.80, 8.00)
Guizhou 52 (2, 52) 0.15 (0.05, 1.00) 7.80 (1.20, 15.60)
Yunnan 26 (6, 32) 0.20 (0.15, 0.55) 5.20 (2.25, 7.80)
Tibet 3 (2, 31) 1.00 (0.40, 1.00) 3.00 (1.40, 20.15)
Shaanxi 1 (0, 52) 0.75 (0.00, 1.00) 0.75 (0.00, 1.50)
Gansu 0 (0, 52) 0.05 (0.00, 1.00) 0.00 (0.00, 31.20)
Qinghai 26 (0, 52) 0.05 (0.00, 1.00) 1.30 (0.00, 13.75)
Ningxia 4 (1, 29) 0.75 (0.20, 1.00) 3.00 (0.40, 13.05)
Xinjiang 52 (0, 52) 0.15 (0.00, 1.00) 7.80 (0.00, 52.00)
National Average 9.95 (3.31, 23.40) 0.68 (0.37, 0.96) 6.77 (2.50, 10.03)

δ is the proportion of those infected with one serotype who are cross-protected against infection from all other serotypes for a fixed duration of k time steps, and the product k ⋅ δ represents the average duration of cross-protection. 95% CIs for the individual parameters are derived from the profile likelihood using the χ2 distribution with 1 degree of freedom.